摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans-iodo(tert-butyldiphenylsilyl benzoate-C4)bis(triphenylphosphine)platinum(II) | 360048-22-2

中文名称
——
中文别名
——
英文名称
trans-iodo(tert-butyldiphenylsilyl benzoate-C4)bis(triphenylphosphine)platinum(II)
英文别名
[tert-butyl(diphenyl)silyl] benzoate;iodoplatinum(1+);triphenylphosphane
trans-iodo(tert-butyldiphenylsilyl benzoate-C4)bis(triphenylphosphine)platinum(II)化学式
CAS
360048-22-2
化学式
C59H53IO2P2PtSi
mdl
——
分子量
1206.09
InChiKey
UIEGGINEIWNPJY-UHFFFAOYSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    参考文献:
    名称:
    A New Methodology for the Preparation of Cationic Organoplatinum(II) Complexes with Hydrogen-Bonding Functionality
    摘要:
    A new methodology for the preparation, of two series of cationic organoplatinum(II) complexes with hydrogen-bonding functionality is described. The mononuclear complexes of the type trans-[Pt(sigma -aryl)L(PPh3)(2)] OTf (L = nicotinic acid, aryl = C-3-benzoic acid (9) or C-4-benzoic acid (10); L = isonicotinic acid, aryl = C-3-benzoic acid (11) or C-4-benzoic acid (12); OTf = trifluoromethanesulfonate (triflate)) constitute the first series, and the dinuclear complexes of the type trans-[Pt(sigma -aryl)(PPh3)(2)(mu -L)Pt(sigma -aryl)(PPh3)(2)](OTf)(2) (L = 1,1-bis(4-pyridyl)ethene, aryl = C-3-benzoic acid (19) or C-4-benzoic acid (20); L = 4,7-phenanthroline, aryl = C-3-benzoic acid (21) or C-4-benzoic acid (22); L = 4,4 ' -bipyridine, aryl = C-3-benzoic acid (23) or C-4-benzoic acid (24)) constitute the second series. The methodology described here involves the protection of the carboxylic acid group of a 3- or 4-iodobenzoic acid precursor as the tert-butyldiphenylsilyl ester, followed by an oxidative addition reaction of the C-I bond with the Pt(0) species Pt(PPh3)4 to yield the key (sigma -aryl)iodoplatinum(II) intermediates 3 and 4, the structures of which were determined by X-ray crystallography. Subsequent treatment of these products with AgOTf, followed by the addition of a suitable monodentate or bridging bidentate N-donor ligand and, finally, facile removal of the silyl protecting group(s) with HOW affords the target complexes with hydrogen-bonding functionality in high yield. Variable-temperature H-1 NMR experiments with the silyl-protected complexes trans[Pt(sigma -aryl)L(PPh3)(2)]OTf (aryl = C-3-tert-butyldiphenylsilyl benzoate, L = nicotinic acid (5) or isonicotinic acid (7)) confirm that a dynamic intramolecular process involving the pyridyl ligand is occurring. The rotational barrier of a pyridyl ligand in an organoplatinum(II) complex is reported for the first time, where DeltaG(double dagger) = 48.3 +/- 0.9 and 45.7 +/- 0.9 kJ mol(-1) for complexes 5 and 7, respectively.
    DOI:
    10.1021/om010127c
  • 作为产物:
    描述:
    四(三苯基膦)铂tert-butyldiphenylsilyl-4-iodobenzoate甲苯 为溶剂, 以96%的产率得到trans-iodo(tert-butyldiphenylsilyl benzoate-C4)bis(triphenylphosphine)platinum(II)
    参考文献:
    名称:
    A New Methodology for the Preparation of Cationic Organoplatinum(II) Complexes with Hydrogen-Bonding Functionality
    摘要:
    A new methodology for the preparation, of two series of cationic organoplatinum(II) complexes with hydrogen-bonding functionality is described. The mononuclear complexes of the type trans-[Pt(sigma -aryl)L(PPh3)(2)] OTf (L = nicotinic acid, aryl = C-3-benzoic acid (9) or C-4-benzoic acid (10); L = isonicotinic acid, aryl = C-3-benzoic acid (11) or C-4-benzoic acid (12); OTf = trifluoromethanesulfonate (triflate)) constitute the first series, and the dinuclear complexes of the type trans-[Pt(sigma -aryl)(PPh3)(2)(mu -L)Pt(sigma -aryl)(PPh3)(2)](OTf)(2) (L = 1,1-bis(4-pyridyl)ethene, aryl = C-3-benzoic acid (19) or C-4-benzoic acid (20); L = 4,7-phenanthroline, aryl = C-3-benzoic acid (21) or C-4-benzoic acid (22); L = 4,4 ' -bipyridine, aryl = C-3-benzoic acid (23) or C-4-benzoic acid (24)) constitute the second series. The methodology described here involves the protection of the carboxylic acid group of a 3- or 4-iodobenzoic acid precursor as the tert-butyldiphenylsilyl ester, followed by an oxidative addition reaction of the C-I bond with the Pt(0) species Pt(PPh3)4 to yield the key (sigma -aryl)iodoplatinum(II) intermediates 3 and 4, the structures of which were determined by X-ray crystallography. Subsequent treatment of these products with AgOTf, followed by the addition of a suitable monodentate or bridging bidentate N-donor ligand and, finally, facile removal of the silyl protecting group(s) with HOW affords the target complexes with hydrogen-bonding functionality in high yield. Variable-temperature H-1 NMR experiments with the silyl-protected complexes trans[Pt(sigma -aryl)L(PPh3)(2)]OTf (aryl = C-3-tert-butyldiphenylsilyl benzoate, L = nicotinic acid (5) or isonicotinic acid (7)) confirm that a dynamic intramolecular process involving the pyridyl ligand is occurring. The rotational barrier of a pyridyl ligand in an organoplatinum(II) complex is reported for the first time, where DeltaG(double dagger) = 48.3 +/- 0.9 and 45.7 +/- 0.9 kJ mol(-1) for complexes 5 and 7, respectively.
    DOI:
    10.1021/om010127c
点击查看最新优质反应信息

文献信息

  • Synthesis and redistribution reactions of asymmetric σ-arylplatinum(II) complexes containing 4,7-phenanthroline
    作者:David P. Gallasch、Susan L. Woodhouse、Louis M. Rendina
    DOI:10.1016/j.jorganchem.2004.01.027
    日期:2004.4
    The mononuclear σ-aryl complexes of the type trans-[Pt(σ-C6H4R)(4,7-phen)(PPh3)2]OTf (R=4-CO2SitBuPh2, 4-CONHMe, 3-CO2SitBuPh2, 3-CONHMe; OTf=trifluoromethanesulfonate) containing a monodentate 4,7-phenanthroline (4,7-phen) ligand were prepared by an oxidative addition reaction of an aryl iodide with Pt(PPh3)4 to yield the key iodoplatinum(II) precursors trans-[PtI(σ-C6H4R)(PPh3)2], followed by halogen
    该类型的单核σ -芳基配合物的反式- [PT(σ-C 6 H ^ 4 R)(4,7-phen)的(PPH 3)2 ]光学传递函数(R = 4-CO 2的Si吨BUPH 2,4-通过芳基化物与PT(PPh)的氧化加成反应制备含有单齿4,7-咯啉(4,7-phen)配体的CONHMe,3-CO 2 Si t BUPh 2,3 -CONHMe; OTf =三氟甲磺酸盐3)4得到关键的(II)前体反式-[PTI(σ- C6 H 4 R)(PPh 3)2],然后进行卤素当量与一当量的4,7-phen置换。的反应反式[PT(σ-C - 6 ħ 4 R)(4,7-phen)的(PPH 3)2 ]光学传递函数与该类型的不稳定配合反式- [PT(OTF)L- 2(σ-C 6 H 4 R ')]](L = PEt 3,R ' = H; L = PPh 3,R ' = 4-CO 2 Si t BUPh
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-3,3''-双([[1,1''-联苯]-4-基)-[1,1''-联萘]-2,2''-二醇 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-2,2'',3,3''-四氢-6,6''-二-9-菲基-1,1''-螺双[1H-茚]-7,7''-二醇 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (6,6)-苯基-C61己酸甲酯 (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,5R)-3,3a,8,8a-四氢茚并[1,2-d]-1,2,3-氧杂噻唑-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aS,8aR)-2-(吡啶-2-基)-8,8a-二氢-3aH-茚并[1,2-d]恶唑 (3aS,3''aS,8aR,8''aR)-2,2''-环戊二烯双[3a,8a-二氢-8H-茚并[1,2-d]恶唑] (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (3S,3aR)-2-(3-氯-4-氰基苯基)-3-环戊基-3,3a,4,5-四氢-2H-苯并[g]吲唑-7-羧酸 (3R,3’’R,4S,4’’S,11bS,11’’bS)-(+)-4,4’’-二叔丁基-4,4’’,5,5’’-四氢-3,3’’-联-3H-二萘酚[2,1-c:1’’,2’’-e]膦(S)-BINAPINE (3-三苯基甲氨基甲基)吡啶 (3-[(E)-1-氰基-2-乙氧基-2-hydroxyethenyl]-1-氧代-1H-茚-2-甲酰胺) (2′′-甲基氨基-1,1′′-联苯-2-基)甲烷磺酰基铝(II)二聚体 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环